DiaMedica Therapeutics In... (DMAC)
DiaMedica Therapeutics Statistics
Share Statistics
DiaMedica Therapeutics has 42.88M shares outstanding. The number of shares has increased by 12.89% in one year.
| 42.88M |
| 12.89% |
| 0.22% |
| 15.74% |
| n/a |
| 7,664 |
| 7.88% |
Short Selling Information
The latest short interest is 856.93K, so 2% of the outstanding shares have been sold short.
| 856.93K |
| 2% |
| 3.17% |
| 8.9 |
Valuation Ratios
The PE ratio is -8.98 and the forward PE ratio is -5.25. DiaMedica Therapeutics's PEG ratio is 0.
| -8.98 |
| -5.25 |
| 0 |
| 2.2 |
| 5.39 |
| -9.93 |
| 0 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for DiaMedica Therapeutics.
| n/a |
| n/a |
| n/a |
| n/a |
Financial Position
The company has a current ratio of 8.28, with a Debt / Equity ratio of 0.01.
| 8.28 |
| 8.28 |
| 0.01 |
| -0.01 |
| -0.02 |
| 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| n/a |
| n/a |
| n/a |
| n/a |
| $-905,333.33 |
| 27 |
| 0 |
| n/a |
Taxes
| 30K |
| -0.12% |
Stock Price Statistics
The stock price has increased by 49.82% in the last 52 weeks. The beta is 1.2, so DiaMedica Therapeutics's price volatility has been higher than the market average.
| 1.2 |
| 49.82% |
| 3.93 |
| 4.74 |
| 49.51 |
| 97,222 |
Balance Sheet
The company has 3.02M in cash and 340K in debt, giving a net cash position of 2.69M.
| 3.02M |
| 340K |
| 2.69M |
| -140M |
| 38.83M |
| 32.76M |
Cash Flow
In the last 12 months, operating cash flow was -22.08M and capital expenditures -25K, giving a free cash flow of -22.1M.
| -22.08M |
| -25K |
| -22.1M |
| -0.55 |
Margins
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
Dividends & Yields
DMAC does not appear to pay any dividends at this time.
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
Analyst Forecast
The average price target for DMAC is $8, which is 95.6% higher than the current price. The consensus rating is "Buy".
| $8 |
| 95.6% |
| Buy |
| 2 |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| n/a |
| n/a |
| n/a |
| n/a |
Stock Splits
The last stock split was on Nov 15, 2018. It was a backward split with a ratio of 1:20.
| Nov 15, 2018 |
| backward |
| 1:20 |
Scores
| 15.17 |
| 2 |